Results: 30
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Galectin-3 in pre-B acute lymphoblastic leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2385, doi. 10.1038/leu.2013.175
- By:
- Publication type:
- Article
A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2301, doi. 10.1038/leu.2013.83
- By:
- Publication type:
- Article
Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2341, doi. 10.1038/leu.2013.94
- By:
- Publication type:
- Article
Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2376, doi. 10.1038/leu.2013.127
- By:
- Publication type:
- Article
Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2413, doi. 10.1038/leu.2013.153
- By:
- Publication type:
- Article
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2393, doi. 10.1038/leu.2013.218
- By:
- Publication type:
- Article
In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2404, doi. 10.1038/leu.2013.203
- By:
- Publication type:
- Article
Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2407, doi. 10.1038/leu.2013.164
- By:
- Publication type:
- Article
Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2379, doi. 10.1038/leu.2013.147
- By:
- Publication type:
- Article
Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2410, doi. 10.1038/leu.2013.159
- By:
- Publication type:
- Article
Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K/mTOR inhibition in myeloma cells is essential for their effective clinical application.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2397, doi. 10.1038/leu.2013.150
- By:
- Publication type:
- Article
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2419, doi. 10.1038/leu.2013.149
- By:
- Publication type:
- Article
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2322, doi. 10.1038/leu.2013.266
- By:
- Publication type:
- Article
Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2351, doi. 10.1038/leu.2013.152
- By:
- Publication type:
- Article
Aberrant expression of CCR4 in diffuse large B-cell lymphoma, not otherwise specified.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2382, doi. 10.1038/leu.2013.128
- By:
- Publication type:
- Article
Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2289, doi. 10.1038/leu.2013.156
- By:
- Publication type:
- Article
Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2422, doi. 10.1038/leu.2013.126
- By:
- Publication type:
- Article
Functional characterization of Foxp3-specific spontaneous immune responses.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2332, doi. 10.1038/leu.2013.196
- By:
- Publication type:
- Article
Vertebral augmentation in the treatment of pathologic compression fractures in 792 patients with multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2391, doi. 10.1038/leu.2013.162
- By:
- Publication type:
- Article
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2280, doi. 10.1038/leu.2013.87
- By:
- Publication type:
- Article
JAK inhibitors suppress t(8;21) fusion protein-induced leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2272, doi. 10.1038/leu.2013.197
- By:
- Publication type:
- Article
SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2388, doi. 10.1038/leu.2013.141
- By:
- Publication type:
- Article
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2357, doi. 10.1038/leu.2013.172
- By:
- Publication type:
- Article
Heterogeneity of outcome with single-agent carfilzomib: all relapsed/refractory myelomas are not created equal.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2269, doi. 10.1038/leu.2013.161
- By:
- Publication type:
- Article
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2366, doi. 10.1038/leu.2013.194
- By:
- Publication type:
- Article
Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2416, doi. 10.1038/leu.2013.130
- By:
- Publication type:
- Article
Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2311, doi. 10.1038/leu.2013.131
- By:
- Publication type:
- Article